Headline News

 

GSK and Alfasigma announce new agreement on linerixibat

Posted on March 10, 2026

Lilly’s Employer Connect platform launches independent program administrators offering tailored obesity coverage options to expand access to patients

Posted on March 10, 2026

Lilly’s releases statement on CMMI BALANCE model for GLP-1 medicines and medicare GLP-1 bridge model

Posted on March 10, 2026

Hims & Hers shift to US weight loss

Posted on March 10, 2026

PADCEV and Keytruda reduce risk of recurrence/death by nearly 50% in cisplatin eligible muscle invasive bladder cancer

Posted on March 03, 2026

Acoziborole Winthrop developed by Sanofi officially receives positive opinion as three-tablet, single-dose treatment for the most common form of sleeping sickness

Posted on March 03, 2026

Dupixent recommended for approval to treat chronic spontaneous urticaria in children with ongoing symptoms

Posted on March 03, 2026

Sanofi’s rilzabrutinib has officially earnt orphan drug designation for IgG4-related disease in Japan

Posted on March 03, 2026

SystImmune and Bristol Myers Squibb present positive phase III topline results for izalontamab brengitecan in unresectable locally advanced or metastatic triple negative breast cancer

Posted on March 03, 2026

ViiV Healthcare highlights new pipeline data for 2 investigational HIV treatment therapies

Posted on March 03, 2026

GSK’s Linerixibat accepted for priority review for cholestatic pruritus in patients with primary biliary cholangitis in China

Posted on March 02, 2026

GSK’s Bepirovirsen accepted for regulatory review as a potential first in class treatment for chronic hepatitis B

Posted on March 02, 2026

Orforglipron highlights superior blood sugar control and weight loss compared to oral semaglutide in head to head type 2 diabetes trial

Posted on March 02, 2026

Lilly’s Olumiant recommended for approval of expanded use for adolescents with severe alopecia areata

Posted on March 02, 2026

FDA set to initiate the review of Moderna’s seasonal influenza vaccine submission

Posted on February 23, 2026